Neuroprotective actions of a histidine analogue in models of ischemic stroke

Journal of Neurochemistry

Volumn 101, Issue 3, 2007, Pages 729-736

  Tang, Sung Chun ^a,b   Arumugam, Thiruma V ^a   Cutler, Roy G ^a   Jo, Dong Gyu ^a,c   Magnus, Tim ^a   Chan, Sic L ^a   Mughal, Mohamed R ^a   Telljohann, Richard S ^a   Nassar, Matthew ^a   Ouyang, Xin ^a   Calderan, Andrea ^d   Ruzza, Paolo ^d   Guiotto, Andrea ^d   Mattson, Mark P ^a,e  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Sungkyunkwan University   (South Korea)

^d Sezione di Padova   (Italy)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carnosine analogue; Ischemic stroke; Lipid peroxidation; Neuroprotection

Indexed keywords

CASPASE 3; GLUCOSE; HISTIDINE DERIVATIVE; HISTIDYL HYDRAZIDE; OXYGEN; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN FUNCTION; CELL DEATH; CELL HYPOXIA; CELL PROTECTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE MODEL; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG POTENCY; EMBRYO; ENZYME SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; BRAIN INFARCTION; CARNOSINE; CASPASE 3; CELL DEATH; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; GLUCOSE; HISTIDINE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

RATTUS;

EID: 34247343207     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04412.x     Document Type: Article

References (48)

1. Aldini G., Facino R. M., Beretta G. Carini M. (2005) Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives. Biofactors 24, 77 87.
2. Arumugam T. V., Salter J. W., Chidlow J. H., Ballantyne C. M., Kevil C. G. Granger D. N. (2004) Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion. Am. J. Physiol. Heart Circ. Physiol. 287, H2555 H2560.
3. Bauer K. (2005) Carnosine and homocarnosine, the forgotten, enigmatic peptides of the brain. Neurochem. Res. 30, 1339 1345.
4. Bederson J. B., Pitts L. H. Tsuiji M. (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 472 476.
5. Begum G., Cunliffe A. Leveritt M. (2005) Physiological role of carnosine in contracting muscle. Int. J. Sport Nutr. Exerc. Metab. 15, 493 514.
6. Biffo S., Grillo M. Margolis F. L. (1990) Cellular localization of carnosine-like and anserine-like immunoreactivities in rodent and avian central nervous system. Neuroscience 35, 637 651.
7. Boldyrev A. A., Dupin A. M., Bunin A. Y., Babizhaev M. A. Severin S. E. (1987) The antioxidative properties of carnosine, a natural histidine containing dipeptide. Biochem. Int. 15, 1105 1113.
8. Boldyrev A. A., Kurella E. G., Rubtsov A. M., Tiulina O. V., Shara M. Shentiurts M. (1992) Direct measurement of the interaction of carnosine and its analogs with free radicals. Biokhimiia 57, 1360 1365.
9. Boldyrev A. A., Koldobski A., Kurella E., Maltseva V. Stvolinski S. (1993) Natural histidine-containing dipeptide carnosine as a potent hydrophilic antioxidant with membrane stabilizing function. A biomedical aspect. Mol. Chem. Neuropathol. 19, 185 192.
10. Boldyrev A. A., Abe H., Stvolinsky S. Tyulina O. (1995) Effects of carnosine and related compounds on generation of free oxygen species: a comparative study. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 112, 481 485.
11. Boldyrev A. A., Stvolinsky S. L., Tyulina O. V., Koshelev V. B., Hori N. Carpenter D. O. (1997) Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals. Cell. Mol. Neurobiol. 17, 259 271.
12. Chan K. M. Decker E. A. (1994) Endogenous skeletal muscle antioxidants. Crit. Rev. Food Sci. Nutr. 34, 403 426.
13. Crush K. G. (1970) Carnosine and related substances in animal tissues. Comp. Biochem. Physiol. 34, 3 30.
14. Dobrota D., Fedorova T., Stvolinsky S., Babusikova E., Likavcanova K., Drgova A., Strapkova A. Boldyrev A. (2005) Carnosine protects the brain of rats and Mongolian gerbils against ischemic injury: after-stroke-effect. Neurochem. Res. 30, 1283 1288.
15. Feigin V. L., Doronin B. M., Popova T. F., Gribatcheva E. V. Tchervov D. V. (2001) Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial. Eur. J. Neurol. 8, 81 85.
16. Garcia J. H. Anderson M. L. (1989) Physiopathology of cerebral ischemia. Crit. Rev. Neurobiol. 4, 303 324.
17. Graham S. H. Chen J. (2001) Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21, 99 109.
18. Guiotto A., Calderan A., Ruzza P., Osler A., Rubini C., Jo D. G., Mattson M. P. Borin G. (2005a) Synthesis and evaluation of neuroprotective alpha,beta-unsaturated aldehyde scavenger histidyl-containing analogues of carnosine. J. Med. Chem. 48, 6156 6161.
19. Guiotto A., Calderan A., Ruzza P. Borin G. (2005b) Carnosine and carnosine-related antioxidants: a review. Curr. Med. Chem. 12, 2293 2315.
20. Gursoy-Ozdemir Y., Can A. Dalkara T. (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35, 1449 1453.
21. Hall E. D. (1995) Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J. Neurol. Sci. 134, S79 S83.
22. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609 1623.
23. Halliwell B. Gutteridge J. M. (1985) The importance of free radicals and catalytic metal ions in human diseases. Mol. Aspects Med. 8, 89 193.
24. Keller J. N., Mark R. J., Bruce A. J., Blanc E., Rothstein J. D., Uchida K., Waeg G. Mattson M. P. (1997) 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80, 685 696.
25. Kruman I., Bruce-Keller A. J., Bredesen D., Waeg G. Mattson M. P. (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17, 5089 5100.
26. Lee J., Chan S. L., Lu C., Lane M. A. Mattson M. P. (2002) Phenformin suppresses calcium responses to glutamate and protects hippocampal neurons against excitotoxicity. Exp. Neurol. 175, 161 167.
27. Margaill I., Plotkine M. Lerouet D. (2005) Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 39, 429 443.
28. Margolis F. L. (1974) Carnosine in the primary olfactory pathway. Science 184, 909 911.
29. Mark R. J., Pang Z., Geddes J. W., Uchida K. Mattson M. P. (1997a) Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17, 1046 1054.
30. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K. Mattson M. P. (1997b) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem. 68, 255 264.
31. Mattson M. P., Duan W., Pedersen W. A. Culmsee C. (2001) Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6, 69 81.
32. McCracken E., Valeriani V., Simpson C., Jover T., McCulloch J. Dewar D. (2000) The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes. J. Cereb. Blood Flow Metab. 20, 1529 1536.
33. Muralikrishna Adibhatla R. Hatcher J. F. (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 40, 376 387.
34. O'Brien J., Wilson I., Orton T. Pognan F. (2000) Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267, 5421 5426.
35. Pedersen W. A., Fu W., Keller J. N., Markesbery W. R., Appel S., Smith R. G., Kasarskis E. Mattson M. P. (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 44, 819 824.
36. RANTTAS Investigators (1996) A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators. Stroke 27, 1453 1458.
37. Sayre L. M., Zelasko D. A., Harris P. L., Perry G., Salomon R. G. Smith M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092 2097.
38. Ste-Marie L., Vachon P., Vachon L., Bemeur C., Guertin M. C. Montgomery J. (2000) Hydroxyl radical production in the cortex and striatum in a rat model of focal cerebral ischemia. Can. J. Neurol. Sci. 27, 152 159.
39. Stuerenburg H. J. (2000) The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases. Biochemistry (Mosc.) 65, 862 865.
40. Stvolinsky S. L. Dobrota D. (2000) Anti-ischemic activity of carnosine. Biochemistry (Mosc.) 65, 849 855.
41. Stvolinsky S. L., Kukley M. L., Dobrota D., Matejovicova M., Tkac I. Boldyrev A. A. (1999) Carnosine: an endogenous neuroprotector in the ischemic brain. Cell. Mol. Neurobiol. 19, 45 56.
42. Stvolinsky S., Kukley M., Dobrota D., Mezesova V. Boldyrev A. (2000) Carnosine protects rats under global ischemia. Brain Res. Bull. 53, 445 448.
43. Tamba M. Torreggiani A. (1999) Hydroxyl radical scavenging by carnosine and Cu (II)-carnosine complexes: a pulse-radiolysis and spectroscopic study. Int. J. Radiat. Biol. 75, 1177 1188.
44. Uno M., Kitazato K. T., Suzue A., Matsuzaki K., Harada M., Itabe H. Nagahiro S. (2005) Inhibition of brain damage by edaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction. Free Radic. Biol. Med. 39, 1109 1116.
45. White M. J., Dicaprio M. J. Greenberg D. A. (1996) Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures. J. Neurosci. Methods 70, 195 200.
46. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R. Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 93, 2696 2701.
47. Yu Z. F., Bruce-Keller A. J., Goodman Y. Mattson M. P. (1998) Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J. Neurosci. Res. 53, 613 625.
48. Zarkovic K. (2003) 4-hydroxynonenal and neurodegenerative diseases. Mol. Aspects Med. 24, 293 303.